Trademarkia Logo

Canada

C$
Trademark Search in Canada
AC IMMUNE

View On IC.GC.CA

AC IMMUNE
SEARCHED

on 30 Jul 2024

Last Applicant/ Owned by

AC Immune SA

EPFL Innovation ParkBuilding BCH-1015 Lausanne,

CH

Serial Number

1987266 filed on 26th Sept 2019

Correspondent Address

GOWLING WLG (CANADA) LLP

1 PLACE VILLE MARIE37TH FLOOR/37E ETAGEMONTREAL

QUÉBEC

CA

H3B3P4

AC IMMUNE

Trademark usage description

antibody reagents for scientific purposes, cell culture reagents for laboratory use, cell culture reagents for scientific or research purposes, proteo Read More

Classification Information

Class [001]
Antibody reagents for scientific purposes, cell culture reagents for laboratory use, cell culture reagents for scientific or research purposes, proteomics analysis test kits comprising reagents for characterizing antibody proteins in a biological sample for scientific research purposes, diagnostic biomarkers for in vitro testing for scientific use, antibody reagents for scientific purposes, biochemicals in the form of monoclonal antibodies for in vitro scientific use, monoclonal antibodies for scientific purposes, reagents for use in the development of antibodies, biological tissue specimens for use in scientific research, biological assays and kits for use in fields of biological and diagnostic testing for scientific and research use, laboratory assay kits, none of the aforesaid goods relating to the development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases.

Classification kind code

11

Class [005]
Pharmaceutical preparations for diagnosing and treating neurological diseases, neurodegenerative diseases, immunological diseases or inflammatory diseases, neurological pharmaceutical preparations for the prevention and treatment of neurodegenerative and neurological diseases, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for use in immunotherapies, biological preparations made from living tissues for use in immunotherapy, clinical diagnostic reagents, diagnostic biomarker reagents for medical purposes, diagnostic chemical reagents for medical purposes, diagnostic reagents and agents for medical diagnostic use, diagnostic test reagents for medical purposes, medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting autoimmune diseases, veterinary diagnostic reagents, protein arrays for medical diagnosis purposes, amino acid preparations for medical purposes, amino acids for veterinary purposes, pharmaceutical antibody preparations for auto-immune diseases, diagnostic reagents for medical purposes, human vaccines, veterinary vaccines, none of the aforesaid goods relating to the development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases.

Classification kind code

11

Class [009]
Electrical, scientific and teaching apparatus and software

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [038]
Telecommunications

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Scientific and technological services, namely biomedical engineering, chemical engineering, engineering in the field of immunopharmaceuticals, custom design and development of chemical reagents and biochemical assays, design and development of medical testing and analysis methods in the field of immunology and scientific research relating to the diagnosis and treatment of neurodegenerative diseases, neurological, immunological diseases or inflammatory diseases, biochemical research, biological therapeutic research services, research in the field of biochemistry, scientific research in the field of pharmacology, pharmaceuticals, and biochemistry, neurological research services, research and development services in the field of pharmaceutical preparations for the diagnosis and treatment of neurological, neurodegenerative diseases, immunological diseases or inflammatory diseases and disorders, providing scientific research information in the fields of biomedicine, biomedical research services, medical research laboratory services chemical laboratory services, scientific research laboratories for conducting research in the field of immunotherapy and neurodegenerative diseases and disorders, veterinary laboratories, chemical research services, medical research services, clinical trials, providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials, consultancy in the fields of biotechnology, chemistry, development of pharmaceutical preparations and medicines for the treatment of neurological diseases, neurodegenerative diseases, immunological diseases or inflammatory diseases, research and development services in the field of immunology, custom design and development of chemical reagents and biochemical assays, analysis in the field of molecular biology, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries, molecular biology advice and scientific research for third parties, research in the fields of biologic therapeutic preparations, engineering in the field of vaccines, antibody engineering, namely, antibody profiling for scientific research purposes, none of the aforesaid services relating to the development of pharmaceutical therapies to prevent, manage, and treat food related, gastrointestinal, allergic and inborn error of metabolism diseases.

Classification kind code

11

Mark Details

Serial Number

1987266

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 30th Jul 2024		Search Recorded
Submitted for opposition 20
on 30th Jul 2024		Examiner's First Report
Submitted for opposition 287
on 19th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 31
on 7th Oct 2019		Formalized
Submitted for opposition 1
on 27th Sept 2019		Created
Submitted for opposition 30
on 26th Sept 2019		Filed